Veronica Bunn Selected Research

ErbB Receptors (EGF Receptor)

1/2023	Characterization and management of adverse events observed with mobocertinib (TAK-788) treatment for EGFR exon 20 insertion-positive non-small cell lung cancer.
1/2021	Activity and Safety of Mobocertinib (TAK-788) in Previously Treated Non-Small Cell Lung Cancer with EGFR Exon 20 Insertion Mutations from a Phase I/II Trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Veronica Bunn Research Topics

Disease

3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2023 - 01/2021
2	Peripheral Nervous System Diseases (PNS Diseases) 12/2021 - 01/2020
2	Mycosis Fungoides 12/2021 - 01/2021
1	Lymphoma (Lymphomas) 10/2022
1	Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral) 10/2022
1	Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma) 10/2022
1	Pain (Aches) 12/2021
1	Cutaneous T-Cell Lymphoma (Lymphoma, T Cell, Cutaneous) 12/2021
1	Pruritus (Itching) 12/2021
1	Primary Cutaneous Anaplastic Large Cell Lymphoma 12/2021
1	T-Cell Lymphoma (Lymphoma, T Cell) 01/2020
1	Neoplasms (Cancer) 01/2020

Drug/Important Bio-Agent (IBA)

3	mobocertinibIBA 01/2023 - 01/2021
3	Brentuximab VedotinIBA 12/2021 - 01/2020
2	ErbB Receptors (EGF Receptor)IBA 01/2023 - 01/2021
2	PlatinumIBA 01/2023 - 12/2021
2	Bexarotene (LGD1069)FDA Link 12/2021 - 01/2020
2	Methotrexate (Mexate)FDA LinkGeneric 12/2021 - 01/2020
1	Doxorubicin (Adriamycin)FDA LinkGeneric 10/2022
1	Prednisone (Sone)FDA LinkGeneric 10/2022
1	Vincristine (Oncovin)FDA LinkGeneric 10/2022
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 10/2022

Therapy/Procedure

2	Therapeutics 10/2022 - 01/2020